Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Walsh

Showing results (421-430 of 561) with videos related to

Pageof 57
Sort By:
BMJ Open|February 26, 2022
Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic reviewYingqi Xiao, Gordon Guyatt, Linan Zeng, et al.
Leukemia|March 5, 2024
5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignanciesJasmine C Wong, Kelley M Weinfurtner, Tamara Westover, et al.
Research Square|October 4, 2023
Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid LeukemiaJeffery Klco, Melvin Thomas, Wenqing Qi, et al.
JAMA|November 10, 2010
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trialThomas F Hiemstra, Michael Walsh, Alfred Mahr, et al.
Canadian Journal of Kidney Health and Disease|March 18, 2015
Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTworkBraden Manns, Brendan Barrett, Michael Evans, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Kidney Medicine|November 12, 2025
The Impact of Hemodiafiltration Versus Hemodialysis on Uremic Symptoms, Physical Function: A Systematic Review and Meta-analysis of Randomized Controlled TrialsYerly Paola Sanchez, Rocio Ayala Romero, Sandra M Campbell, et al.
Nature Communications|January 29, 2015
Coherent spin control of a nanocavity-enhanced qubit in diamondLuozhou Li, Tim Schröder, Edward H Chen, et al.
Canadian Journal of Kidney Health and Disease|March 27, 2024
The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory AnalysisArrti A Bhasin, Jennifer M MacRae, Braden Manns, et al.
Pageof 57

Showing results (421-430 of 561) with videos related to

Sort By:
Pageof 57
BMJ Open|February 26, 2022
Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic reviewYingqi Xiao, Gordon Guyatt, Linan Zeng, et al.
Leukemia|March 5, 2024
5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignanciesJasmine C Wong, Kelley M Weinfurtner, Tamara Westover, et al.
Research Square|October 4, 2023
Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid LeukemiaJeffery Klco, Melvin Thomas, Wenqing Qi, et al.
JAMA|November 10, 2010
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trialThomas F Hiemstra, Michael Walsh, Alfred Mahr, et al.
Canadian Journal of Kidney Health and Disease|March 18, 2015
Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTworkBraden Manns, Brendan Barrett, Michael Evans, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Kidney Medicine|November 12, 2025
The Impact of Hemodiafiltration Versus Hemodialysis on Uremic Symptoms, Physical Function: A Systematic Review and Meta-analysis of Randomized Controlled TrialsYerly Paola Sanchez, Rocio Ayala Romero, Sandra M Campbell, et al.
Nature Communications|January 29, 2015
Coherent spin control of a nanocavity-enhanced qubit in diamondLuozhou Li, Tim Schröder, Edward H Chen, et al.
Canadian Journal of Kidney Health and Disease|March 27, 2024
The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory AnalysisArrti A Bhasin, Jennifer M MacRae, Braden Manns, et al.
Pageof 57